companydata.dkcompanydata.dk

Allarity Therapeutics A/S: Financial statements 2013

CVR: 28106351

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

Allarity Therapeutics A/S (CVR 28106351) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 4,049,607 and a net result of DKK -3,539,007 compared with DKK -2,768,795 the year before. That is an increase of 2.7% compared with the year before. The profit margin was -87.4%. Equity in the 2013 report amounted to DKK 10,417,511. The solvency ratio was 84.3%.

Revenue
DKK 4,049,607
Gross Profit
DKK 183,601
Profit/Loss
DKK -3,539,007
Equity
DKK 10,417,511
Total Assets
DKK 12,357,153

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20134M184K-3.5M10.4M-
20123.9M566K-2.8M4.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

Allarity Therapeutics A/S: The 2012 annual report is outJun 3, 2013

Allarity Therapeutics A/S has published its annual report for 2012. Revenue came to DKK 3,943,474, and the net result was DKK -2,768,795.

About Allarity Therapeutics A/S

Allarity Therapeutics A/S was a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company has been dissolved on 16 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ONCOLOGY VENTURE A/S and MEDICAL PROGNOSIS INSTITUTE A/S. The company has 6 employees (2021). In 2024, the company reported a gross profit of DKK -81,000 and a net result of DKK -83,000 compared with DKK -406,000 the year before. Equity in the 2024 report amounted to DKK 0.

Source: annual report 2024, Danish Business Authority